Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$25.26 - $29.6 $209,556 - $245,561
-8,296 Reduced 39.46%
12,730 $356,000
Q1 2024

Apr 18, 2024

SELL
$25.89 - $29.73 $286,032 - $328,457
-11,048 Reduced 34.45%
21,026 $583,000
Q4 2023

Feb 01, 2024

SELL
$26.13 - $33.94 $463,467 - $601,993
-17,737 Reduced 35.61%
32,074 $923,000
Q3 2023

Oct 17, 2023

BUY
$32.09 - $37.51 $277,963 - $324,911
8,662 Added 21.05%
49,811 $1.65 Million
Q2 2023

Jul 27, 2023

BUY
$36.12 - $41.79 $95,790 - $110,827
2,652 Added 6.89%
41,149 $1.51 Million
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $61,605 - $80,201
1,564 Added 4.23%
38,497 $1.57 Million
Q4 2022

Jan 25, 2023

BUY
$41.75 - $54.5 $66,424 - $86,709
1,591 Added 4.5%
36,933 $0
Q3 2022

Oct 20, 2022

SELL
$43.76 - $53.42 $5,163 - $6,303
-118 Reduced 0.33%
35,342 $1.55 Million
Q2 2022

Jul 19, 2022

SELL
$46.53 - $55.17 $3,489 - $4,137
-75 Reduced 0.21%
35,460 $1.86 Million
Q1 2022

Apr 08, 2022

SELL
$45.75 - $56.69 $14,914 - $18,480
-326 Reduced 0.91%
35,535 $1.84 Million
Q4 2021

Feb 01, 2022

BUY
$41.32 - $61.25 $20,246 - $30,012
490 Added 1.39%
35,861 $2.12 Million
Q3 2021

Nov 05, 2021

BUY
$39.25 - $50.42 $24,335 - $31,260
620 Added 1.78%
35,371 $1.52 Million
Q2 2021

Aug 11, 2021

BUY
$35.91 - $40.68 $78,463 - $88,885
2,185 Added 6.71%
34,751 $1.43 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $9,879 - $11,142
295 Added 0.91%
32,566 $1.18 Million
Q4 2020

Feb 09, 2021

BUY
$33.47 - $42.56 $119,320 - $151,726
3,565 Added 12.42%
32,271 $1.19 Million
Q3 2020

Nov 10, 2020

BUY
$31.75 - $37.25 $911,415 - $1.07 Million
28,706 New
28,706 $1.05 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Nikulski Financial, Inc. Portfolio

Follow Nikulski Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikulski Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikulski Financial, Inc. with notifications on news.